NCT00035503View on ClinicalTrials.gov

Multicenter Trial For Patients With Acute Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Crohn's Disease
Interventions
DRUG

etiprednol dicloacetate

Trial Locations (11)

12208

Richard MacDermott, Albany

20010

Washington Hospital Center, Washington D.C.

33021

Mark Lamet, Hollywood

Wayne Schonfeld, Hollywood

33140

Mount Sinai Medical Center, Miami Beach

40202

Gerald Dryden, Louisville

60637

University of Chicago Hospital Medical Center, Chicago

80262

University of Colorado Medical Center, Denver

94304

Stuart Weisman, Palo Alto

M5G 1XB

Hillary Steinhart, Toronto

H3G 1A4

Gary Wild, Montreal

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00035503 - Multicenter Trial For Patients With Acute Crohn's Disease | Biotech Hunter | Biotech Hunter